Federal Register / Vol. 87, No. 44 / Monday, March 7, 2022 / Notices 12709 

may instead submit to CDC a signed 

statement from a local health authority, 

on the health authority’s official 

letterhead, indicating that the health 

authority has declined to participate in 

deliberations and/or sign the port 

agreement, i.e., a ‘‘Statement of NonParticipation.’’ The cruise ship operator 

can submit to CDC documentation of 

attempted communication with the 

local health authority regarding the port 

agreement if a response is not received 

or if the local health authority declines 

to provide a signed statement. 

Additionally, the cruise ship operator 

may enter into a multi-port agreement 

(as opposed to a single port agreement) 

provided that all relevant port and local 

health authorities (including the state 

health authorities) are signatories to the 

agreement. 

During discussions with cruise ship 

operators, port authorities, and state and 

local health authorities, all parties 

requested CDC assistance with the 

required agreements. In response to 

these requests, CDC has created specific 

guidance for additional reference. 

Inspections 

Cruise ships participating in CDC’s 

program are subject to in-person 

inspections by CDC inspectors. The 

cruise ship operator’s properties and 

records must be made available for 

inspection to allow CDC to ascertain 

compliance with its requirements. Such 

properties and records include but are 

not limited to vessels, facilities, 

vehicles, equipment, communications, 

manifests, list of passengers, laboratory 

test results, and employee and 

passenger health records. CDC has 

issued additional technical guidance 

outlining the specific areas that may be 

inspected and corresponding 

recommendations. 

CDC has provided, and will continue 

to provide as necessary, the technical 

instructions for the COVID–19 Program 

for Cruise Ships. CDC will work closely 

with cruise industry, state, territorial, 

and local health authorities, and seaport 

partners to evaluate the program 

components no later than March 18, 

2022, and update them as needed. The 

evaluation will include a review of all 

public health recommendations and 

guidance issued as part of the program 

based on public health conditions and 

available scientific evidence. 

CDC requests OMB approval for an 

estimated 17,532 annual burden hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form or information collection name Number of 

respondents 

Number 

responses 

per 

respondent 

Avg. burden 

per response 

(hours) 

Cruise ship brand/operator ............................. COVID–19 Program for Cruise Ships Notice 

of Participation/Nonparticipation.

20 1 300/60 

Cruise ship brand/operator ............................. Cruise Ship Vaccination Status Classification 130 1 5/60 

Cruise ship parent company ........................... COVID–19 Response Plan ............................ 3 1 2,400/60 

Cruise ship physician ...................................... Enhanced Data Collection (EDC) During 

COVID–19 Pandemic Form (Daily).

130 365 20/60 

Cruise ship physician ...................................... Cruise COVID–19 Case Investigation Worksheet (if necessary).104 1 30/60 

Cruise ship physician ...................................... Cruise COVID–19 Contact Investigation 

Worksheet (if necessary).

24 1 30/60 

Cruise ship brand/operator ............................. Agreement with Health Care Organization 

with signoff from Local Health Authorities.

30 1 600/60 

Cruise ship brand/operator ............................. Agreement with Port of Entry with signoff 

from Local Health Authority.

30 1 600/60 

Cruise ship brand/operator ............................. Agreement with Housing Facility with signoff 

from Local Health Authority.

30 1 600/60 

Cruise ship operator ....................................... Inspections ..................................................... 130 2 120/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–04668 Filed 3–4–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to CDC’s Advisory 

Committee to the Director (ACD) 

Health Equity Workgroup (HEW) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), is seeking nominations 

for membership on the Advisory 

Committee to the Director (ACD) Health 

Equity Workgroup (HEW). The HEW 

will consist of approximately 15 

members who are experts in fields 

associated with health equity; public 

health science and practice; public 

health policy development, analysis, 

and implementation. 

DATES: Nominations for membership on 

the HEW workgroup must be received 

no later than March 17, 2022. Late 

nominations will not be considered for 

membership. 

ADDRESSES: All nominations (cover 

letters and curriculum vitae) should be 

emailed to ACDirector@cdc.gov with the 

subject line: ‘‘Nomination for CDC ACD 

HEW Workgroup.’’ 

FOR FURTHER INFORMATION CONTACT: 

Kerry Caudwell, MPA, Centers for 

Disease Control and Prevention, Office 

of the Chief of Staff, 1600 Clifton Road 

NE, MS H21–10, Atlanta, Georgia 

30329–4027, Telephone: (404) 639– 

7000; Email Address: ACDirector@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The purpose of the ACD, 

CDC is to advise the Secretary, HHS, 

and the Director, CDC, on policy and 

broad strategies that will enable CDC to 

fulfill its mission of protecting health 

through health promotion, prevention, 

and preparedness. The ACD, CDC 

consists of up to 15 non-federal 

members, including the Chair, 

knowledgeable in areas pertinent to the 

CDC mission, such as health policy, 

public health, global health, 

preparedness, preventive medicine, the 

faith-based and community-based 

sector, and allied fields. 


khammond on DSKJM1Z7X2PROD with NOTICES
12710 Federal Register / Vol. 87, No. 44 / Monday, March 7, 2022 / Notices 

Purpose: The establishment and 

formation of the HEW is to provide 

input to the ACD, CDC on agency-wide 

activities related to the scope and 

implementation of CDC’s CORE (an 

acronym for C-cultivate comprehensive 

health equity science, O-optimize 

interventions, R-reinforce and expand 

robust partnerships, and E-enhance 

capacity and workforce diversity and 

inclusion) strategy around health equity. 

The HEW membership will be 

comprised of approximately 15 

members. It will be chaired by two 

current ACD, CDC Special Government 

Employees. HEW co-chairs will present 

their findings, observations, and work 

products at one or more ACD, CDC 

meetings for discussion, deliberation, 

and decisions (final recommendations 

to CDC). 

Nomination Criteria: HEW members 

will serve terms ranging from six 

months to one year and be required to 

attend HEW meetings approximately 1– 

2 times per month (virtually or inperson), and contribute time in between 

meetings for research, consultation, 

discussion, and writing assignments. 

Nominations are being sought for 

individuals who have the expertise and 

qualifications necessary to contribute to 

the accomplishments of the 

committee’s/workgroup’s objectives. 

Nominees will be selected based on 

expertise in the fields of health equity; 

public health science and practice; 

public health policy development, 

analysis, and implementation. To 

ensure a diverse workgroup 

composition, nominees with front line 

and field experience at the local, state, 

tribal and territorial levels are 

encouraged to apply. This includes 

nominees with experience working for, 

and with, community-based 

organizations and other non-profit 

organizations. Federal employees will 

not be considered for membership. 

Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of the HEW’s 

objectives. 

HHS policy stipulates that 

membership be balanced in terms of 

points of view represented and the 

workgroup’s function. Appointments 

shall be made without discrimination 

based on age, race, ethnicity, gender, 

sexual orientation, gender identity, HIV 

status, disability, and cultural, religious, 

or socioeconomic status. Nominees 

must be U.S. citizens and cannot be fulltime employees of the U.S. Government. 

Current participation on federal 

workgroups or prior experience serving 

on a federal advisory committee does 

not disqualify a candidate; however, 

HHS policy is to avoid excessive 

individual service on advisory 

committees and multiple committee 

memberships. Interested candidates 

should submit the following items: 

D A one-half to one-page cover letter 

that includes your understanding of, 

and commitment to, the time and work 

necessary; one to two sentences on your 

background and experience; and one to 

two sentences on the skills/perspective 

you would bring to the HEW. 

D Current curriculum vitae which 

highlights the experience and work 

history being sought relevant to the 

criteria set forth above, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

Nominations may be submitted by the 

candidate him or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–04690 Filed 3–4–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—CE22–003, 

Rigorously Evaluating Programs and 

Policies To Prevent Child Sexual 

Abuse (CSA); Amended Notice of 

Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel (SEP)—CE22– 

003, Rigorously Evaluating Programs 

and Policies to Prevent Child Sexual 

Abuse (CSA), April 19–20, 2022, 8:30 

a.m., EDT–5:30 p.m., EDT, Web 

Conference, in the original FRN. The 

meeting was published in the Federal 

Register on January 14, 2022, Volume 

87, Number 10, page 2439. 

The meeting is being amended to 

change the meeting date and should 

read as follows: 

CE22–003, Rigorously Evaluating 

Programs and Policies to Prevent Child 

Sexual Abuse (CSA): April 19, 2022. 

The meeting is closed to the public. 

FOR FURTHER INFORMATION CONTACT: 

Aisha L. Wilkes, M.P.H., Scientific 

Review Officer, National Center for 

Injury Prevention and Control, CDC, 

4770 Buford Highway NE, Mailstop 

S106–9, Atlanta, Georgia 30341, 

Telephone (404) 639–6473, AWilkes@

cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–04681 Filed 3–4–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CE22– 

002, Grants To Support New 

Investigators in Conducting Research 

Related To Preventing Interpersonal 

Violence Impacting Children and 

Youth; Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel (SEP)—RFA– 

CE22–002, Grants to Support New 

Investigators in Conducting Research 

Related to Preventing Interpersonal 

Violence Impacting Children and Youth, 

March 8–9, 2022, 8:30 a.m., EDT–5:30 

p.m., EDT, Web Conference, in the 

original FRN. The meeting was 

published in the Federal Register on 

January 5, 2022, Volume 87, Number 3, 

page 460. 

The meeting is being amended to 

change the meeting date and should 

read as follows: 

RFA–CE22–002, Grants to Support 

New Investigators in Conducting 

Research Related to Preventing 


khammond on DSKJM1Z7X2PROD with NOTICES